• 1
    Danis VA, Kulesz AJ, Kelly DE, Nelson DS, Brooks PM. The effect of goal treatment on monocyte interleukin-1 production in rheumatoid arthritis. A prospective study. Rheumatol Int 1990; 10:1538.
  • 2
    Danis VA, Franic GM, Rathjen DA, Laurent RM, Brooks PM. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis 1992; 51:94650.
  • 3
    Danis VA, March LM, Nelson DS, Brooks PM. Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 1987; 14:3339.
  • 4
    Danis VA, Kulesz AJ, Nelson DS, Brooks PM. The effect or gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis. Clin Exp Immunol 1990; 79:33540.
  • 5
    Molvig J, Back L, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988, 27:70516.
  • 6
    Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 1989; 143:91322.
  • 7
    Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:12337.
  • 8
    Endres S, Ghorbani R, Lonnemann G, Van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 1988; 49:42438.
  • 9
    Endres S, Cannon JG, Ghorbani R et al. In vitro production of IL-1 beta. IL-1 alpha, TNF and IL-2 in healthy subjects; distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19:232733.
  • 10
    Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91:4034.
  • 11
    Bailly S, di Giovine FS, Blakemore AI, Duff GW. Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol 1993; 23:12405.
  • 12
    di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1:450.
  • 13
    Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992; 1:353.
  • 14
    Jacob CO, Mykytyn K, Tashman N. DNA polymorphism in cytokine genes based on length variation in simple-sequence tandem repeats. Immunogenetics 1993; 38:2517.
  • 15
    Danis VA, Kulesz AJ, Nelson DS, Brooks PM. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha. Clin Exp Immunol 1990; 80:43543.
  • 16
    Danis V, Millington M. Gentle separations suit the cell. Today's Life Science 1994; 6:4044.
  • 17
    Danis VA, Franic GM, Rathjen DA, Brooks PM. The effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 2 (IL-2), interferon (IFN)-gamma, tumour necrosis factor (TNF)alpha and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp Immunol 1991; 85:14350.
  • 18
    Wyman AR, White R. A highly polymorphic locus in human DNA. Proc Natl Acad Sci USA 1980; 77:67548.
  • 19
    Cluitmans FH, Esendam BH, Landegent JE, Willemze R, Falkenburg JH. Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymphokine Cytokine Res 1993; 12:45764.
  • 20
    Fiehn C, Wermann M, Pezzutto A, Hufner M, Heilig B. The plasma GM-CSF concentrations in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy. Z Rheumatol 1992; 51:1216.
  • 21
    Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989; 83:87682.
  • 22
    Field M, Clinton L. Expression of GM-CSF receptor in rheumatoid arthritis (letter). Lancet 1993; 342:1244.
  • 23
    Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993; 151:685361.
  • 24
    Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267:233018.
  • 25
    Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor β mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 1993; 150:355360.
  • 26
    Fenton MJ, Buras JA, Donnelly RP. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 1992; 149:12838.
  • 27
    De Waal Malefyt R, Figdor CG, de Vries JE. Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. Res Immunol 1993; 144:62933.
  • 28
    De Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151:637081.
  • 29
    Hallek M, Lepisto EM, Slattery KE, Griffin JD, Ernst TJ. Interferon-gamma increases the expression of the gene encoding the beta subunit of the granulocyte-macrophage colony-stimulating factor receptor. Blood 1992; 80:173642.
  • 30
    Muzio M, Re F, Sironi M et al. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 1994; 83:173843.
  • 31
    Poutsiaka DD, Mengozzi M, Vannier E, Sinha B, Dinarello CA. Cross-linking of the beta-glucan receptor on human monocytes. results in interleukin-1 receptor antagonist but not interleukin-l production. Blood 1993; 82:3695700.
  • 32
    Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993; 178:162936.
  • 33
    Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83:1138.
  • 34
    Kuhl D, de la Fuente J, Chaturvedi M et al. Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter. Cell 1987; 50:105769.
  • 35
    Raj NB, Cheung SC, Rosztoczy I, Pitha PM. Mouse genotype affects inducible expression of cytokine genes. J Immunol 1992; 148:193440.
  • 36
    Granowitz EV, Vannier E, Poutsiaka DD, Dinarello CA. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 1992; 79:23649.
  • 37
    Conti P, Feliciani C, Barbacane RC et al. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells. Immunology 1992; 77:24550.
  • 38
    Cork MJ, Tarlow JK, Blakemore AI et al. Psoriasis and interleukin-1. A translation. J R Coll Physicians Lond 1993; 27:366.
  • 39
    Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:63742.